NCT01183091|Completed
Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AF
EVABLAF
Loading search results
EVABLAF
Sponsor study identifier
observational
503
1 country
1
Study Start
April 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2008
Actual (reported)Study Completion
October 2010
Actual (reported)The atrial fibrillation is the most frequent confusions of the heart rhythm: his preValencia increases with the age, and the investigators consider that beyond 65 years, 5 % of the population is affected by this arrhythmia. It entails a greater risk of morbidity (thromboembolic accident and cardiac insufficiency) and of cardiovascular mortality (mortality increased by a factor 1,7 - 2) independents of the causal pathology or the associated risk factors. For all these reasons, it raises a real problem of public health.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2005
Date type not reportedThis date has not been verified as actual or estimated.
July 2008
Actual (reported)August 16, 2010
Actual (reported)August 17, 2010
Actual (reported)October 2010
Actual (reported)Success of ablation
The principal criterion of the medical evaluation is the success of ablation defined by the absence of repetition of AF (or the persistence of the sinusal rhythm) after the 3 months period following the procedures of ablation based on ECG or holter registration. These patients are likely to be able to profit from another procedure of ablation so necessary.
after 3 months
Description of the patients experiencing an AF ablation
Ablation of atrial fibrillation
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Description of the patients experiencing a first AF ablation
Service de cardiologie - Hôpital Lariboisière
Paris, 75010, France
Antoine LEENHARDT, MD,PhD
Assistance Publique - Hôpitaux de Paris
503 participants (actual enrollment reported by the registry).
First Submitted
August 16, 2010
First Posted
August 17, 2010
Study Start
April 2005
Date type not reportedThis date has not been verified as actual or estimated.
Effect of H2 inhalation therapy on early recurrence after atrial fibrillation ablation.
Contact the study team to confirm eligibility.
Primary Completion
July 2008
Actual (reported)Study Completion
October 2010
Actual (reported)Last Updated
September 20, 2012
Record last verified: 2012-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: